Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrea Verdugo‐Meza"'
Autor:
Prakhar Sengar, Patricia Juárez, Andrea Verdugo-Meza, Danna L. Arellano, Akhil Jain, Kanchan Chauhan, Gustavo A. Hirata, Pierrick G. J. Fournier
Publikováno v:
Journal of Nanobiotechnology, Vol 16, Iss 1, Pp 1-19 (2018)
Abstract Background Photodynamic therapy is a promising cancer therapy modality but its application for deep-seated tumor is mainly hindered by the shallow penetration of visible light. X-ray-mediated photodynamic therapy (PDT) has gained a major att
Externí odkaz:
https://doaj.org/article/ee7919f1dc1348e09d7a2b3bc28bb321
Autor:
Jiayu Ye, Lauren A. E. Erland, Sandeep K. Gill, Stephanie L. Bishop, Andrea Verdugo-Meza, Susan J. Murch, Deanna L. Gibson
Publikováno v:
Biomolecules, Vol 11, Iss 5, p 738 (2021)
The use of live biotherapeutic products (LBPs), including single strains of beneficial probiotic bacteria or consortiums, is gaining traction as a viable option to treat inflammatory-mediated diseases like inflammatory bowel disease (IBD). However, L
Externí odkaz:
https://doaj.org/article/afecd45791b5419ba9315758fff3ff39
Autor:
Danna L. Arellano, Patricia Juárez, Andrea Verdugo‐Meza, Paloma S. Almeida‐Luna, Juan A. Corral‐Avila, Florian Drescher, Felipe Olvera, Samanta Jiménez, Bennett D. Elzey, Theresa A. Guise, Pierrick G.J. Fournier
Publikováno v:
Journal of Bone and Mineral Research. 37:1446-1463
Immunotherapies use components of the immune system, such as T cells, to fight cancer cells, and are changing cancer treatment, causing durable responses in some patients. Bone metastases are a debilitating complication in advanced breast and prostat
Autor:
null Danna L. Arellano, null Patricia Juárez, null Andrea Verdugo‐Meza, null Paloma S. Almeida‐Luna, null Juan A. Corral‐Avila, null Florian Drescher, null Felipe Olvera, null Samanta Jiménez, null Bennett D. Elzey, null Theresa A. Guise, null Pierrick GJ. Fournier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f00b110681429dcbeb50126f4821b1
https://doi.org/10.1002/jbmr.4615/v3/response1
https://doi.org/10.1002/jbmr.4615/v3/response1
Autor:
Sandeep K. Gill, Susan J. Murch, Jiayu Ye, Lauren A. E. Erland, Andrea Verdugo-Meza, Deanna L. Gibson, Stephanie L. Bishop
Publikováno v:
Biomolecules
Volume 11
Issue 5
Biomolecules, Vol 11, Iss 738, p 738 (2021)
Volume 11
Issue 5
Biomolecules, Vol 11, Iss 738, p 738 (2021)
The use of live biotherapeutic products (LBPs), including single strains of beneficial probiotic bacteria or consortiums, is gaining traction as a viable option to treat inflammatory-mediated diseases like inflammatory bowel disease (IBD). However, L
Autor:
Andrea Verdugo-Meza, Danna L. Arellano, Samanta Jiménez, Patricia Juárez, Pierrick G.J. Fournier, Juan A. Corral-Avila, Felipe Olvera-Rodriguez, Florian Drescher
Publikováno v:
Cancer Research. 80:6199-6199
Bone metastases are a frequent complication in patients with advanced breast cancer and remain incurable. Thus, we need to explore new options for their treatment. Immunotherapy for the treatment of cancer is promising but remains untested for bone m
T cell suppression by the bone microenvironment increases bone metastases from breast cancer in mice
Autor:
Danna L Arellano, Andrea Verdugo-Meza, Florian Drescher, Felipe Olvera-Rodriguez, Patricia Juarez, Pierrick Fournier
Publikováno v:
The Journal of Immunology. 202:138.10-138.10
Bone metastases are a frequent complication of breast cancer and cannot be cured. Immunotherapy could be used for their treatment. However, its efficiency could be limited by the ability of T cells to increase bone resorption that supports cancer cel
Autor:
Ubaldo Ramírez Esquivel, Norma Carrasco Esparza, Alejandro Organista Esparza, Verónica Viñuela Berni, Istvan Berczi, Andrea Verdugo Meza, Andrés Quintanar Stephano, Kalman Kovacs
Publikováno v:
The FASEB Journal. 28